The current study is not without limitations, however.
Recall bias could be considered one potential challenge,
since some of the information was based on the recall of
the study participants. Furthermore, it was not clear
whether all cases had MDR-TB before or after undergoing
first-line TB treatment, since DST was not done before
they took first-line TB treatment or Category II
regimens